Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Capecitabine clinical data and product introduction announced at ASCO

May 22, 1998

Techniclone evaluates VEGF as a tumor marker

May 22, 1998

Long-term prevention of precancerous colonic polyp formation demonstrated for FGN-1

May 22, 1998

Gd-Tex phase Ib/II interim results presented at ASCO

May 22, 1998

ONYX-015: phase I and II results in various cancers discussed at ASCO

May 21, 1998

Comparable antitumor effects of SEF-19 and CGS-20267 in rat breast cancer model

May 21, 1998

Targeted Genetics' E1A gene therapy headed for phase II trials in head and neck cancer

May 20, 1998

T-cell gene therapy developed at Cell Genesys markedly reduces TAG-72 blood levels

May 20, 1998

Preliminary clinical results indicate good tolerability for LGD-1550 in cancer patients

May 20, 1998

Promising phase I/II findings in NSCLC reported for INGN-201 at ASCO

May 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.